WFDC2 and ovarian carcinoma: Other biomarkers were developed to improve specificity for ovarian carcinomas diagnosis such as Human Epididymis Protein 4 (HE4) [8], which is only slightly expressed in the epithelium tissues of respiratory and reproductive organs but overexpressed in ovarian tumours (especially in serous and endometrioid ovarian carcinomas) [10].